Olympus Recalls Single Use Biopsy Valves Due to Potential Rubber Fragment Detachment
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Olympus Corporation of the Americas has recalled over 95,000 boxes of single-use biopsy valves because rubber fragments may detach during medical procedures.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 2, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevice.
What Happened
Olympus Corporation of the Americas has initiated a voluntary recall of its Single use Biopsy Valve, Model MAJ-210. The recall was triggered by the discovery of a potential defect where rubber fragments may detach from the valve during clinical use. This device is designed to be attached to the instrument channel port of compatible endoscopes to prevent the reflux of body fluids.
Which Products Are Affected
The recall affects the following medical device:
- Product Name: Olympus Single use Biopsy Valve
- Model/Catalog Number: MAJ-210
- UDI-DI: 14953170152433, 14953170452069
- Lot Numbers: All lot numbers are included in this recall.
- Quantity: 95,882 boxes (each containing 20 units).
- Recall Number: Z-1488-2026
What You Should Do
Olympus initiated the recall process on January 29, 2026, via a notification letter to customers. Healthcare facilities and distributors should immediately check their inventory for Model MAJ-210 biopsy valves. Affected units should be quarantined and handled according to the instructions provided in the firm's notification letter. For further information or assistance regarding this recall, contact Olympus Corporation of the Americas at their headquarters in Center Valley, PA.
Why This Matters
The detachment of rubber fragments during an endoscopic procedure poses a significant safety risk, as foreign material could potentially enter a patient's body or interfere with the proper functioning of medical instruments.
Source
Information provided by the FDA under Recall Event ID 98240.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.